<p><i>Panel A:</i> Different concentrations of a mixture of PLA<sub>2</sub>R derived peptides were used to inhibit the reactivity to the PLA<sub>2</sub>R whole molecule in an addressable laser bead assay. The reactivity showed a significant, dose dependent inhibition. The inhibition with a control peptide (GE-1) was significantly lower. All values are expressed as residual reactivity after inhibition (in %) compared to the sample without inhibitor or control. <i>Panel B:</i> The peptide mixture together with seven individual PLA<sub>2</sub>R peptides and a control peptide were used at a concentration of 126 µg/mL. Besides the peptide mixture, peptide 3 and peptide 4 showed inhibition of anti-PLA<sub>2</sub>R antibodies. All values are expre...
<p>“*” and “**” denote statistical significance with p<0.05 and p<0.005, respectively, from student ...
<p>(a) LCP-2 (A<sub>291</sub>Y-GCN4-LCP) is more immunogenic than peptide 2 (A<sub>291</sub>Y-GCN4 w...
<p>A: Inhibition of serum IgA reactivity to glycoprotein 2 (GP2). A serum with high anti-GP2 IgA lev...
<p><b>A.</b> The binding of affinity purified anti-PsA peptide antibodies to solid phase fibrillin i...
<p>Competition ELISA to determine the capacity of peptides to block binding of anti-ApoA-I antibodie...
<p>Grey scale heat map representation of results from SPOT used to detect PLA<sub>2</sub>R epitopes....
<p>A competitive ELISA was performed using the antigen peptide LPAPTS as the competitor for the VP1 ...
<p><b>A.</b> Binding of affinity purified anti-PsA peptide antibodies to solid phase fibrillin 3, de...
a<p>Data are expressed as fluorescence index when peptides were used at 200 µM ± S.D. The results sh...
<p>Reduction in titer was determined by addition of non-biotinylated peptide to 2 different samples ...
<p>To verify potential epitopes, synthetic peptides (see <a href="http://www.plosone.org/article/inf...
<p>(A) Schematic representation of peptides used for scanning the binding sites of anti-MPER. (B) Re...
<p>Antibodies raised against LTA from <i>E. faecalis</i> 12030 were evaluated for their ability to b...
Antiphospholipid syndrome is characterized by a prothrombotic state and the presence of &beta;2-...
<p>Sera were used at final dilution of 1:50 and the strain tested was <i>E</i>. <i>faecium</i> E155....
<p>“*” and “**” denote statistical significance with p<0.05 and p<0.005, respectively, from student ...
<p>(a) LCP-2 (A<sub>291</sub>Y-GCN4-LCP) is more immunogenic than peptide 2 (A<sub>291</sub>Y-GCN4 w...
<p>A: Inhibition of serum IgA reactivity to glycoprotein 2 (GP2). A serum with high anti-GP2 IgA lev...
<p><b>A.</b> The binding of affinity purified anti-PsA peptide antibodies to solid phase fibrillin i...
<p>Competition ELISA to determine the capacity of peptides to block binding of anti-ApoA-I antibodie...
<p>Grey scale heat map representation of results from SPOT used to detect PLA<sub>2</sub>R epitopes....
<p>A competitive ELISA was performed using the antigen peptide LPAPTS as the competitor for the VP1 ...
<p><b>A.</b> Binding of affinity purified anti-PsA peptide antibodies to solid phase fibrillin 3, de...
a<p>Data are expressed as fluorescence index when peptides were used at 200 µM ± S.D. The results sh...
<p>Reduction in titer was determined by addition of non-biotinylated peptide to 2 different samples ...
<p>To verify potential epitopes, synthetic peptides (see <a href="http://www.plosone.org/article/inf...
<p>(A) Schematic representation of peptides used for scanning the binding sites of anti-MPER. (B) Re...
<p>Antibodies raised against LTA from <i>E. faecalis</i> 12030 were evaluated for their ability to b...
Antiphospholipid syndrome is characterized by a prothrombotic state and the presence of &beta;2-...
<p>Sera were used at final dilution of 1:50 and the strain tested was <i>E</i>. <i>faecium</i> E155....
<p>“*” and “**” denote statistical significance with p<0.05 and p<0.005, respectively, from student ...
<p>(a) LCP-2 (A<sub>291</sub>Y-GCN4-LCP) is more immunogenic than peptide 2 (A<sub>291</sub>Y-GCN4 w...
<p>A: Inhibition of serum IgA reactivity to glycoprotein 2 (GP2). A serum with high anti-GP2 IgA lev...